<DOC>
	<DOCNO>NCT03100682</DOCNO>
	<brief_summary>Due immunosuppressive therapy , solid-organ transplant ( SOT ) recipient bear 10 100 time high risk human papillomavirus ( HPV ) -associated malignancy healthy individual . The objective observational , non-interventional multi-national , multi-centre research project gain insight current HPV vaccination strategy investigate immune response different routinely administer HPV vaccine European paediatric SOT candidate immunocompromised transplant recipient , enable patient risk vaccination failure identify .</brief_summary>
	<brief_title>Prevention Human Papillomavirus ( HPV ) Infection Paediatric Kidney Liver Transplant Recipients Paediatric Patients With Advanced Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Paediatric Kidney and/or Liver transplant recipient Paediatric patient CKD Who receive HPV vaccination accord countryspecific vaccine schedule No HPV vaccination accord countryspecific vaccine schedule No write inform consent</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>